Ask most women what vitamin D does and you'll get some version of "bone health" and then a pause. That's not wrong, but it's a fraction of the picture, and it undersells why deficiency is worth taking seriously — the Centers for Disease Control's own nutrition surveys have found low vitamin D status in roughly a quarter of the U.S. population, with rates running noticeably higher among women with darker skin tones, those who cover skin for religious or cultural reasons, and anyone living north of about 37 degrees latitude — a line that runs through San Francisco, roughly through the middle of the U.S., and includes essentially all of the UK, Ireland, and northern Europe.
Why deficiency is so easy to miss
Vitamin D synthesis in skin depends on UVB exposure, and UVB is filtered out at low sun angles — which means from roughly October through March at latitudes above 35 degrees north, your skin isn't making meaningful vitamin D regardless of how much time you spend outside. Add sunscreen (which blocks the UVB synthesis pathway almost entirely at SPF 30 and above), indoor desk jobs, and higher melanin content in skin — which requires more UV exposure to produce the same amount of vitamin D — and you have a nutrient that a huge share of adult women simply aren't making enough of for five or six months a year.
The symptoms, when they show up at all, are frustratingly generic: fatigue that doesn't resolve with sleep, low mood in winter months, bone or muscle aches that get written off as normal wear. None of that reliably points to vitamin D on its own, which is exactly why it goes undiagnosed as often as it does. The only way to actually know your status is a blood test measuring 25-hydroxyvitamin D — not a guess based on how much time you spend outdoors, and not a proxy from any other test.
How much you actually need
The National Institutes of Health's Office of Dietary Supplements sets the RDA at 600 IU (15 mcg) per day for women ages 1 through 70, rising to 800 IU (20 mcg) after age 70. That's the amount believed sufficient for bone health in nearly all healthy people — it is explicitly not the amount some researchers believe is optimal for broader health outcomes, and that gap is the source of most of the confusion around vitamin D dosing. The Institute of Medicine defines sufficiency as a blood level of 20 ng/mL or higher, deficiency below 12 ng/mL, and an in-between "insufficient" zone from 12 to 20 ng/mL. The Endocrine Society, a separate professional body, uses a higher bar — around 30 ng/mL for sufficiency — and that disagreement between two credible institutions is worth knowing about rather than glossing over, because it means the same blood test result can be read as "fine" or "low" depending on whose guideline your doctor follows.
The tolerable upper intake level is 4,000 IU (100 mcg) per day for adults — vitamin D toxicity is rare but real, and it typically comes from megadose supplements taken over months, not from food or reasonable sun exposure. More is not automatically better here, and anyone taking more than 2,000 IU a day without a doctor's guidance and a follow-up blood test is guessing rather than optimizing.
Where it actually comes from
Fatty fish is the strongest food source by a wide margin: a 3-ounce serving of cooked sockeye salmon delivers roughly 570 IU, and canned pink salmon or sardines aren't far behind. Fortified foods close most of the rest of the gap for people who don't eat fish regularly — a cup of fortified milk carries about 120 IU, fortified orange juice runs similar, and most fortified breakfast cereals add another 40–100 IU per serving. Egg yolks contribute a modest 40 IU each, and UV-exposed mushrooms (check the label — not all are treated this way) can carry a meaningful dose, sometimes several hundred IU per serving, depending on processing.
Realistically, food alone rarely closes the gap for anyone who isn't eating fatty fish two or three times a week, which is most people. A daily D3 supplement in the 1,000–2,000 IU range is a reasonable, low-risk way to cover the shortfall for most adult women, though it's worth getting a baseline blood test first if you can — supplementing blind means you can't tell whether you've actually fixed anything.
Who should actually get tested, not just guess
Some groups carry meaningfully higher deficiency risk and shouldn't rely on a general recommendation the way a low-risk adult might. Women with darker skin tones need substantially more sun exposure to synthesize the same amount of vitamin D as someone with lighter skin, because melanin competes with the same UVB photons that trigger synthesis — studies have found deficiency rates two to three times higher among Black women compared to white women in the same city, same season, same sun exposure habits. Pregnant women have elevated needs tied to fetal skeletal development, and several obstetric guidelines now recommend baseline testing at the first prenatal visit rather than waiting for symptoms. Women over 65 synthesize vitamin D less efficiently in skin regardless of sun exposure — aging skin has a reduced capacity to convert the precursor compound, independent of how much time is spent outdoors — which is part of why the RDA steps up to 800 IU after 70.
One caveat worth flagging plainly: vitamin D supplements can interact with certain medications, including some cholesterol-lowering statins and corticosteroids, and high-dose supplementation alongside calcium carries a small but real risk of kidney stones in people already prone to them. None of this is a reason to avoid supplementing at a normal dose — it's a reason to mention it to a doctor or pharmacist rather than assuming a vitamin sold over the counter is automatically risk-free at any dose.
What the research actually shows — and doesn't
The most rigorous evidence on vitamin D supplementation comes from the VITAL trial, an NIH-funded study led by researchers at Brigham and Women's Hospital that followed nearly 26,000 U.S. adults for roughly five years, randomizing them to either 2,000 IU of daily vitamin D3 or a placebo. The headline result, published in the New England Journal of Medicine in 2019, was a letdown for anyone hoping for a dramatic finding: supplementation did not significantly lower overall rates of cancer or cardiovascular disease compared to placebo. That's an important, unglamorous fact, and it's worth saying plainly rather than burying it under better news, because a lot of supplement marketing quietly ignores it.
The better news came from a more specific angle. A VITAL substudy focused on autoimmune disease, published a few years later, found that participants taking daily vitamin D3 had a meaningfully lower rate of newly diagnosed autoimmune conditions — reduced by roughly a fifth over five years compared to placebo — one of the few placebo-controlled results in the vitamin D research world that has actually held up under scrutiny. That's not a reason to expect vitamin D to prevent cancer or heart disease, because the same trial found it doesn't. It is a reason to take a normal blood level seriously if autoimmune conditions run in your family.
Get the blood test before you decide how seriously to take any of this. A 25-hydroxyvitamin D panel is inexpensive, usually covered by insurance if a doctor orders it as part of routine bloodwork, and it's the only way to move from guessing to knowing where you actually stand.